Figure 5.
LTA1-mediated protection from H1N1 flu challenge is associated with humoral immunity post-challenge (serum IgM, IgG, and IgA antibodies, lung CD19 B-cells). Groups of C57Bl/6 mice (7–9 weeks of age, n = 4) were left unvaccinated (unvacc.) or IN immunized with 3.6 μg HA-content FZ alone (FZ) or with 10 μg LTA1 (FZ + LTA1) on day 0 (prime) or days 0 and 21 (prime/boost). All mice were challenged 14 days after the last vaccination with 2xLD50 H1N1. (A) Serum anti-FZ IgM, IgG, or IgA levels analyzed from day 3 or day 6 post-H1N1 challenged mice by ELISA (dotted line on IgM graphs at level of non-specific/background binding). (B) Total lung B-cells from day 3 or day 6 post-H1N1 challenged mice quantified by cytometric analysis of homogenized right lobe lung cells gated live-cell positive, dump channel (Gr1, CD11c) negative and CD19+. (C) Correlation of all post-challenge serum IgM, IgG, or IgA data to lung H1N1 viral RNA levels with Spearman correlation coefficient (r) and P-value indicated. Bars at mean + SEM with significance by one-way ANOVA with Dunnett’s post-test compared to FZ group (*P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001, ns = not significant).